# Protect and Improve Cluster of Differentiation 4 (CD4) Cells and B Cells Lymphocytes

> **NCT04770701** · PHASE4 · COMPLETED · sponsor: **Trieu, Nguyen Thi, M.D.** · enrollment: 60 (actual)

## Conditions studied

- HIV-1-infection
- AIDS

## Interventions

- **DRUG:** Ahah Drug
- **DEVICE:** Ahah Placebo

## Key facts

- **NCT ID:** NCT04770701
- **Lead sponsor:** Trieu, Nguyen Thi, M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2021-01-08
- **Final completion:** 2021-01-10
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04770701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04770701, "Protect and Improve Cluster of Differentiation 4 (CD4) Cells and B Cells Lymphocytes". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04770701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*